Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany), M. Polke** (Heidelberg, Germany), S. Walsh (London, United Kingdom), H. Collard (San Francisco, United States of America), N. Chaudhuri (Manchester, United Kingdom), S. Avdeev (Moscow, Russian Federation), J. Behr (Gauting, Germany), G. Calligero (Cape Town, South Africa), T. Corte (Sydney, Australia), K. Flaherty (Ann Arbor, United States of America), M. Funke (Bern, Switzerland), M. Kolb (Hamilton, Canada), Y. Kondoh (Aichi, Japan), T. M. Maher (London, United Kingdom), M. Molina Molina (Barcelona, Spain), A. Morais (Porto, Portugal), K. Moor (Rotterdam, Netherlands), J. Morisset (Quebec, Canada), C. Pereira (São Paulo, Brazil), S. Quadrelli (Buenos Aires, Argentina), M. Selman (México City, Mexico), A. Tzouvelekis (Athens, Greece), C. Vancheri (Catania, Italy), V. Vicens-Zygmunt (Barcelona, Spain), J. Waelscher (Heidelberg, Germany), W. Wuyts (Leuven, Belgium), M. Wijsenbeek** (Rotterdam, Netherlands), V. Cottin** (Lyon, France), E. Bendstrup** (Aarhus, Denmark). A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey. 542

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019 Year: 2020 Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170050; 10.1183/16000617.0050-2017 Year: 2017 Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Late-breaking abstract: Pathological analysis of acute exacerbation of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm Source: Eur Respir J 2015; 46: 512-520 Year: 2015 Inpatient acute exacerbations of chronic obstructive pulmonary disease clinical pathway: development and initial experience Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 A proof of concept study by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD): A qualitative exploratory study of patients’ needs following discharge Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe Year: 2020 The effects of national lockdown on incidence of acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Source: Eur Respir J 2006; 27: 143-150 Year: 2006 Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 The challenge of acute exacerbation of pulmonary fibrosis Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 An eHealth program to reduce hospitalizations due to acute exacerbation of chronic obstructive pulmonary disease – a real-life study Source: Virtual Congress 2020 – Digital technologies in airway diseases Year: 2020 Fatal acute exacerbation of idiopathic pulmonary fibrosis: report of 4 cases Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Source: Eur Respir J 2015; 46: 883-886 Year: 2015 Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Self-efficacy. Does it change as a result of pulmonary rehabilitation? A pilot study Source: Annual Congress 2006 - Effective strategies for chronic respiratory patient management Year: 2006 Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020